Dr. Sridhar Vasudevan

Biography

Sridhar Vasudevan is an Associate Professor in the Department of Pharmacology at the University of Oxford, leading a translational pharmacology lab that focuses on discovering small-molecule therapeutics for psychiatric disorders, metabolic diseases, and neurodegeneration. His work aims to identify novel drug targets across multiple biological systems including sleep/wake regulation and intracellular signaling pathways. Vasudevan integrates deep mechanistic pharmacology with translational medicine, utilizing expertise in GPCR pharmacology and metabolic regulation to understand disease pathophysiology and optimize candidates for clinical validation. His notable translational outcomes include participation in Phase 2 trials for adenosine receptor modulator CT1500 and bipolar disorder candidate ebselen. He has a strong background in signaling biology, having completed his DPhil at Oxford, along with a postdoctoral fellowship in psychiatric and metabolic pharmacology. Vasudevan is dedicated to education, teaching advanced pharmacology and neuroscience, and supervising DPhil students and postdoctoral researchers in his lab. He is actively involved in departmental and university committees that promote translational research and scientist welfare.

Research Interests

Experience